A Sputum 6 Gene Expression Signature Predicts Inflammatory Phenotypes and Future Exacerbations of COPD

References

• LozanoR, NaghaviM, ForemanK, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-023245604
   PubMed Web of Science ®Google Scholar
• QuaderiSA, HurstJR. The unmet global burden of COPD. Glob Health Epidemiol Genom. 2018;3:e4. doi:10.1017/gheg.2018.129868229
   PubMed Web of Science ®Google Scholar
• McDonaldVM, HigginsI, WoodLG, et al. Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense? Thorax. 2013;68(7):691–694. doi:10.1136/thoraxjnl-2012-20264623503624
   PubMed Web of Science ®Google Scholar
• GeorgeL, BrightlingCE. Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease. Ther Adv Chronic Dis. 2016;7(1):34–51. doi:10.1177/204062231560925126770668
   PubMed Web of Science ®Google Scholar
• BafadhelM, McKennaS, TerryS, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662–671. doi:10.1164/rccm.201104-0597OC21680942
   PubMed Web of Science ®Google Scholar
• BainesKJ, PavordID, GibsonPG. The role of biomarkers in the management of airways disease. Int J Tuberc Lung Dis. 2014;18(11):1264–1268. doi:10.5588/ijtld.14.022625299856
   PubMed Web of Science ®Google Scholar
• BainesKJ, SimpsonJL, WoodLG, et al. Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes. J Allergy Clin Immunol. 2014;133(4):997–1007. doi:10.1016/j.jaci.2013.12.109124582314
   PubMed Web of Science ®Google Scholar
• BainesKJ, SimpsonJL, WoodLG, et al. Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples. J Allergy Clin Immunol. 2011;127(1):153–160. doi:10.1016/j.jaci.2010.10.02421211650
   PubMed Web of Science ®Google Scholar
• BerthonBS, GibsonPG, WoodLG, et al. A sputum gene expression signature predicts oral corticosteroid response in asthma. Eur Respir J. 2017;49(6):1700180. doi:10.1183/13993003.00180-201728663317
   PubMed Web of Science ®Google Scholar
• FrickerM, GibsonPG, PowellH, et al. A sputum 6-gene signature predicts future exacerbations of poorly controlled asthma. J Allergy Clin Immunol. 2019;144(1):51–60.e11. doi:10.1016/j.jaci.2018.12.102030682452
   PubMed Web of Science ®Google Scholar
• BainesKJ, Fu-J-J, McDonaldV, et al. Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease. Int J Chron Obstruct Pulmon Dis. 2017;12:541–550. doi:10.2147/COPD.S11944328223794
   PubMed Web of Science ®Google Scholar
• Fu-J-J, McDonaldVM, BainesKJ, et al. Airway IL-1β and systemic inflammation as predictors of future exacerbation risk in asthma and COPD. Chest. 2015;148(3):618–629. doi:10.1378/chest.14-233725950204
   PubMed Web of Science ®Google Scholar
• From the global strategy for the diagnosis and management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD) 2016 [Internet]. Available from: http://goldcopd.org/. Accessed 1011, 2016.
   Google Scholar
• CharlsonME, PompeiP, AlesKL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-83558716
   PubMedGoogle Scholar
• JonesPW, QuirkFH, BaveystockCM, et al. A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992;145:1321–1327. doi:10.1164/ajrccm/145.6.13211595997
   PubMed Web of Science ®Google Scholar
• CelliBR, CoteCG, MarinJM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. doi:10.1056/NEJMoa02132214999112
   PubMed Web of Science ®Google Scholar
• MillerM. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.0003480516055882
   PubMed Web of Science ®Google Scholar
• SimpsonJL, SCOTTR, BOYLEMJ, et al. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11(1):54–61. doi:10.1111/j.1440-1843.2006.00784.x16423202
   PubMed Web of Science ®Google Scholar
• HurstJR, VestboJ, AnzuetoA, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa090988320843247
   PubMed Web of Science ®Google Scholar
• LeighR, PizzichiniMMM, MorrisMM, et al. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Euro Respir J. 2006;27(5):964–971. doi:10.1183/09031936.06.00072105
   PubMed Web of Science ®Google Scholar
• NegewoN, McDonaldV, BainesK, et al. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1495–1504. doi:10.2147/COPD.S10033827445469
   PubMed Web of Science ®Google Scholar
• PavordID, BrightlingCE, WoltmannG, et al. Non-eosinophilic corticosteroid unresponsive asthma. Lancet. 1999;353:2213–2214. doi:10.1016/S0140-6736(99)01813-910392993
   PubMed Web of Science ®Google Scholar
• SimpsonJL, PowellH, BainesKJ, et al. The effect of azithromycin in adults with stable neutrophilic COPD: a double blind randomised, placebo controlled trial. PLoS One. 2014;9(8):e105609. doi:10.1371/journal.pone.010560925148049
   PubMed Web of Science ®Google Scholar
• Wesolowska-AndersenA, SeiboldMA. Airway molecular endotypes of asthma: dissecting the heterogeneity. Curr Opin Allergy Clin Immunol. 2015;15(2):163–168. doi:10.1097/ACI.000000000000014825961390
   PubMed Web of Science ®Google Scholar
• WoodruffPG, BousheyHA, DolganovGM, et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci USA. 2007;104(40):15858–15863. doi:10.1073/pnas.070741310417898169
   PubMed Web of Science ®Google Scholar
• ChristensonSA, SteilingK, van den BergeM, et al. Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191:758–766. doi:10.1164/rccm.201408-1458OC25611785
   PubMed Web of Science ®Google Scholar
• YanX, ChuJ-H, GomezJ, et al. Noninvasive analysis of the sputum transcriptome discriminates clinical phenotypes of asthma. Am J Respir Crit Care Med. 2015;191(10):1116–1125. doi:10.1164/rccm.201408-1440OC25763605
   PubMed Web of Science ®Google Scholar
• PooleA, UrbanekC, EngC, et al. Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease. J Allergy Clin Immunol. 2014;133(3):670–678. doi:10.1016/j.jaci.2013.11.02524495433
   PubMed Web of Science ®Google Scholar
• GibsonPG, McDonaldVM. Phenotyping asthma and chronic obstructive pulmonary disease (COPD). BRN Rev. 2016;2:239–252.
   Google Scholar
• KuoCS, PavlidisS, LozaM, et al. A transcriptome-driven analysis of epithelial brushings and bronchial biopsies to define asthma phenotypes in U-BIOPRED. Am J Respir Crit Care Med. 2017;195:443–455. doi:10.1164/rccm.201512-2452OC27580351
   PubMed Web of Science ®Google Scholar
• LeonidasDD, ElbertBL, ZhouZ, et al. Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins. Structure. 1995;3:1379–1393. doi:10.1016/S0969-2126(01)00275-18747464
   PubMed Web of Science ®Google Scholar
• TrivediNN, CaugheyGH. Mast cell peptidases: chameleons of innate immunity and host defense. Am J Respir Cell Mol Biol. 2010;42(3):257–267. doi:10.1165/rcmb.2009-0324RT19933375
   PubMed Web of Science ®Google Scholar
• DwyerDF, BarrettNA, AustenKF, et al. Expression profiling of constitutive mast cells reveals a unique identity within the immune system. Nat Immunol. 2016;17(7):878. doi:10.1038/ni.344527135604
   PubMed Web of Science ®Google Scholar
• WangG, BainesKJ, FuJJ, et al. Sputum mast cell subtypes relate to eosinophilia and corticosteroid response in asthma. Eur Respir J. 2016;47(4):1123–1133. doi:10.1183/13993003.01098-201526699720
   PubMed Web of Science ®Google Scholar
• BelEH, Ten BrinkeA. New anti-eosinophil drugs for asthma and COPD: targeting the trait! Chest. 2017;152:1276–1282. doi:10.1016/j.chest.2017.05.01928583618
   PubMed Web of Science ®Google Scholar
• KoutsokeraA, KostikasK, NicodLP, et al. Pulmonary biomarkers in COPD exacerbations: a systematic review. Respir Res. 2013;14(1):111. doi:10.1186/1465-9921-14-11124143945
   PubMed Web of Science ®Google Scholar
• KeeneJD, JacobsonS, KechrisK, et al. Biomarkers predictive of exacerbations in the SPIROMICS and COPD Gene cohorts. Am J Respir Crit Care Med. 2017;195(4):473–481. doi:10.1164/rccm.201607-1330OC27579823
   PubMed Web of Science ®Google Scholar
• CulpittSV, MAZIAKW, LOUKIDISS, et al. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(5):1635–1639. doi:10.1164/ajrccm.160.5.981105810556133
   PubMed Web of Science ®Google Scholar
• KeatingsVM, JatakanonA, WorsdellYM, et al. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med. 1997;155:542–548. doi:10.1164/ajrccm.155.2.90321929032192
   PubMed Web of Science ®Google Scholar
• SiddiquiS, BrightlingCE. Airways disease: phenotyping heterogeneity using measures of airway inflammation. Allergy Asthma Clin Immunol. 2007;3:60–69. doi:10.1186/1710-1492-3-2-6020525145
   PubMedGoogle Scholar
• DasguptaA, NeighbourH, NairP. Targeted therapy of bronchitis in obstructive airway diseases. Pharmacol Ther. 2013;140(3):213–222. doi:10.1016/j.pharmthera.2013.07.00123845862
   PubMed Web of Science ®Google Scholar